Metallothioneins and copper metabolism are candidate therapeutic targets in Huntington's disease.

SL Hands, R Mason, MU Sajjad, Flaviano Giorgini, A Wyttenbach

Research output: Contribution to JournalConference Article/Conference Proceedingspeer-review

Fingerprint

Dive into the research topics of 'Metallothioneins and copper metabolism are candidate therapeutic targets in Huntington's disease.'. Together they form a unique fingerprint.

Medicine & Life Sciences

Chemical Compounds